ASGCT 2026 Annual Meeting
Conference Focus
Gene and cell therapy: manufacturing, homology-directed repair, stakeholder engagement
Overview
The ASGCT 2026 Annual Meeting, hosted by the American Society of Gene & Cell Therapy, is the premier global gathering for professionals in the gene and cell therapy sector. This in-person event in Boston serves as a critical nexus for researchers, clinicians, and industry leaders to share breakthroughs in genetic medicine. The conference covers the entire spectrum of the field, from foundational science and homology-directed repair mechanisms to the complexities of large-scale manufacturing and regulatory pathways. Its unique value lies in bridging the gap between cutting-edge academic research and commercial clinical application, fostering essential stakeholder engagement to accelerate the delivery of transformative therapies to patients.
Why Attend
Professionals should attend to gain exclusive insights into the latest clinical trial data and manufacturing innovations. It offers unparalleled networking with key opinion leaders, regulators, and potential partners. Attendees will acquire strategic knowledge on navigating complex regulatory landscapes and optimizing CMC processes, providing a competitive edge in the rapidly evolving gene and cell therapy market.
Key Topics & Sessions
- •Homology-Directed Repair (HDR) Mechanisms
- •Viral and Non-Viral Vector Manufacturing
- •Clinical Trial Design for Rare Diseases
- •Regulatory Pathways for Advanced Therapies
- •CMC and Quality Control Strategies
- •Gene Editing Safety and Off-Target Analysis
- •Patient Advocacy and Stakeholder Engagement
- •Commercialization and Market Access
- •Immunogenicity in Gene Therapy
- •Next-Generation Cell Therapy Platforms
Who Should Attend
Conference History
The American Society of Gene & Cell Therapy (ASGCT) was founded in 1996 to advance knowledge, awareness, and education in the field. Since its inception, the Annual Meeting has grown from a small academic gathering into the largest and most influential event in the global gene and cell therapy industry.
Venue & Location
Menino Convention & Exhibition Center, Boston, MA
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About the ASGCT 2026 Annual Meeting Conference
ASGCT 2026 Annual Meeting is a in-person event scheduled for 2026-05-11 to 2026-05-15 in Menino Convention & Exhibition Center, Boston, MA. The conference focuses on gene and cell therapy: manufacturing, homology-directed repair, stakeholder engagement. This event is categorized under Clinical Operations, Quality & Manufacturing, Regulatory & Compliance in our conference directory.
The ASGCT 2026 Annual Meeting, hosted by the American Society of Gene & Cell Therapy, is the premier global gathering for professionals in the gene and cell therapy sector. This in-person event in Boston serves as a critical nexus for researchers, clinicians, and industry leaders to share breakthroughs in genetic medicine. The conference covers the entire spectrum of the field, from foundational science and homology-directed repair mechanisms to the complexities of large-scale manufacturing and regulatory pathways. Its unique value lies in bridging the gap between cutting-edge academic research and commercial clinical application, fostering essential stakeholder engagement to accelerate the delivery of transformative therapies to patients.
Professionals attending conferences like ASGCT 2026 Annual Meeting gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
Regulatory conferences are essential for staying current with evolving requirements from the FDA, EMA, and other global regulatory bodies. Understanding compliance frameworks such as 21 CFR Part 11 and ICH guidelines is critical for pharmaceutical software development and validation.
Quality and manufacturing conferences address GMP compliance, process validation, Pharma 4.0 digital transformation, and continuous improvement methodologies. Organizations such as ISPE and PDA are leading voices in pharmaceutical engineering and manufacturing excellence.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.